California Public Employees Retirement System Ngm Biopharmaceuticals Inc Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$15.06 - $30.03 $730,410 - $1.46 Million
-48,500 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$16.21 - $31.44 $85,491 - $165,814
-5,274 Reduced 9.81%
48,500 $1.47 Million
Q3 2020

Nov 05, 2020
BUY
$15.59 - $19.97 $12,253 - $15,696
786 Added 1.48%
53,774 $856,000
Q2 2020

Aug 12, 2020
BUY
$11.97 - $23.47 $225,490 - $442,127
18,838 Added 55.16%
52,988 $1.05 Million
Q1 2020

May 12, 2020
BUY
$10.0 - $19.51 $341,500 - $666,266
34,150 New
34,150 $421,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email